Highlights newsletter 2 ESMO 2012
This newsletter presents you the following presentations:
3. Array CGH and DNA sequencing to personalise therapy for patients with metastatic breast cancer
4. Progression-free survival is a surrogate for overall survival in metastatic breast cancer